GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma AD-Sofia (XBUL:SFA) » Definitions » 3-Year Revenue Growth Rate

Sopharma AD-Sofia (XBUL:SFA) 3-Year Revenue Growth Rate : 5.30% (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Sopharma AD-Sofia 3-Year Revenue Growth Rate?

Sopharma AD-Sofia's Revenue per Share for the three months ended in Dec. 2023 was лв2.90.

During the past 12 months, Sopharma AD-Sofia's average Revenue per Share Growth Rate was 0.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was 5.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was 8.00% per year. During the past 10 years, the average Revenue per Share Growth Rate was 9.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Sopharma AD-Sofia was 14.40% per year. The lowest was 4.30% per year. And the median was 9.80% per year.


Competitive Comparison of Sopharma AD-Sofia's 3-Year Revenue Growth Rate

For the Medical Distribution subindustry, Sopharma AD-Sofia's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sopharma AD-Sofia's 3-Year Revenue Growth Rate Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sopharma AD-Sofia's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Sopharma AD-Sofia's 3-Year Revenue Growth Rate falls into.



Sopharma AD-Sofia 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Sopharma AD-Sofia  (XBUL:SFA) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Sopharma AD-Sofia 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Sopharma AD-Sofia's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Sopharma AD-Sofia (XBUL:SFA) Business Description

Traded in Other Exchanges
Address
5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 11, Sofia, BGR, 1756
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are organized based on the production of finished products which include Tablet dosage forms, Ampoule dosage forms, Medical products, Other forms, and Other revenue. Geographically company operates in Bulgaria and internationally.

Sopharma AD-Sofia (XBUL:SFA) Headlines

No Headlines